Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Huang JY, Larose TL, Luu HN, Wang R, Fanidi A, Alcala K, Stevens VL, Weinstein SJ, Albanes D, Caporaso NE, Purdue MP, Ziegler RG, Freedman ND, Lan Q, Prentice RL, Pettinger M, Thomson CA, Cai Q, Wu J, Blot WJ, Shu XO, Zheng W, Arslan AA, Zeleniuch-Jacquotte A, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Stampfer MJ, Han J, Giles GG, Hodge AM, Severi G, Johansson M, Grankvist K, Langhammer A, Hveem K, Xiang YB, Li HL, Gao YT, Visvanathan K, Ueland PM, Midttun Ø, Ulvi A, Buring JE, Lee IM, Sesso HD, Gaziano JM, Manjer J, Relton C, Koh WP, Brennan P, Johansson M, Yuan JM.

Int J Cancer. 2020 May 1;146(9):2394-2405. doi: 10.1002/ijc.32555. Epub 2019 Jul 22.

PMID:
31276202
2.

Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3).

Zuo H, Ueland PM, Midttun Ø, Tell GS, Fanidi A, Zheng W, Shu X, Xiang Y, Wu J, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough ML, Weinstein SJ, Albanes D, Ziegler RG, Freedman ND, Caporaso NE, Langhammer A, Hveem K, Næss M, Buring JE, Lee I, Gaziano JM, Severi G, Zhang X, Stampfer MJ, Han J, Zeleniuch-Jacquotte A, Marchand LL, Yuan J, Wang R, Koh W, Gao Y, Ericson U, Visvanathan K, Jones MR, Relton C, Brennan P, Johansson M, Ulvik A.

Ann Oncol. 2019 Mar 1;30(3):478-485. doi: 10.1093/annonc/mdz002.

3.

Is high vitamin B12 status a cause of lung cancer?

Fanidi A, Carreras-Torres R, Larose TL, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Pettinger M, Cai Q, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Stampfer MJ, Smith-Warner SA, Giovannucci E, Giles GG, Hodge AM, Severi G, Johansson M, Grankvist K, Langhammer A, Brumpton BM, Wang R, Gao YT, Ericson U, Bojesen SE, Arnold SM, Koh WP, Shu XO, Xiang YB, Li H, Zheng W, Lan Q, Visvanathan K, Hoffman-Bolton J, Ueland PM, Midttun Ø, Caporaso NE, Purdue M, Freedman ND, Buring JE, Lee IM, Sesso HD, Michael Gaziano J, Manjer J, Relton CL, Hung RJ, Amos CI, Johansson M, Brennan P; LC3 consortium and the TRICL consortium.

Int J Cancer. 2019 Sep 15;145(6):1499-1503. doi: 10.1002/ijc.32033. Epub 2019 Jan 15.

4.

Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Ward HA, Whitman J, Muller DC, Johansson M, Jakszyn P, Weiderpass E, Palli D, Fanidi A, Vermeulen R, Tjønneland A, Hansen L, Dahm CC, Overvad K, Severi G, Boutron-Ruault MC, Affret A, Kaaks R, Fortner R, Boeing H, Trichopoulou A, La Vecchia C, Kotanidou A, Berrino F, Krogh V, Tumino R, Ricceri F, Panico S, Bueno-de-Mesquita HB, Peeters PH, Nøst TH, Sandanger TM, Quirós JR, Agudo A, Rodríguez-Barranco M, Larrañaga N, Huerta JM, Ardanaz E, Drake I, Brunnström H, Johansson M, Grankvist K, Travis RC, Freisling H, Stepien M, Merritt MA, Riboli E, Cross AJ.

Eur J Clin Nutr. 2019 Aug;73(8):1122-1132. doi: 10.1038/s41430-018-0271-2. Epub 2018 Oct 18.

5.

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Larose TL, Guida F, Fanidi A, Langhammer A, Kveem K, Stevens VL, Jacobs EJ, Smith-Warner SA, Giovannucci E, Albanes D, Weinstein SJ, Freedman ND, Prentice R, Pettinger M, Thomson CA, Cai Q, Wu J, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Stampfer MJ, Hodge AM, Giles GG, Severi G, Johansson M, Grankvist K, Wang R, Yuan JM, Gao YT, Koh WP, Shu XO, Zheng W, Xiang YB, Li H, Lan Q, Visvanathan K, Hoffman Bolton J, Ueland PM, Midttun Ø, Caporaso N, Purdue M, Sesso HD, Buring JE, Lee IM, Gaziano JM, Manjer J, Brunnström H, Brennan P, Johansson M.

Int J Epidemiol. 2018 Dec 1;47(6):1760-1771. doi: 10.1093/ije/dyy100.

6.

No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).

Muller DC, Hodge AM, Fanidi A, Albanes D, Mai XM, Shu XO, Weinstein SJ, Larose TL, Zhang X, Han J, Stampfer MJ, Smith-Warner SA, Ma J, Gaziano JM, Sesso HD, Stevens VL, McCullough ML, Layne TM, Prentice R, Pettinger M, Thomson CA, Zheng W, Gao YT, Rothman N, Xiang YB, Cai H, Wang R, Yuan JM, Koh WP, Butler LM, Cai Q, Blot WJ, Wu J, Ueland PM, Midttun Ø, Langhammer A, Hveem K, Johansson M, Hultdin J, Grankvist K, Arslan AA, Le Marchand L, Severi G, Johansson M, Brennan P.

Ann Oncol. 2018 Jun 1;29(6):1468-1475. doi: 10.1093/annonc/mdy104.

7.

Impaired functional vitamin B6 status is associated with increased risk of lung cancer.

Theofylaktopoulou D, Midttun Ø, Ueland PM, Meyer K, Fanidi A, Zheng W, Shu XO, Xiang YB, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, Wu J, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough MM, Weinstein SJ, Albanes D, Ziegler R, Freedman ND, Langhammer A, Hveem K, Naess M, Sesso HD, Gaziano JM, Buring JE, Lee IM, Severi G, Zhang X, Stampfer MJ, Han J, Smith-Warner SA, Zeleniuch-Jacquotte A, Le Marchand L, Yuan JM, Wang R, Butler LM, Koh WP, Gao YT, Rothman N, Ericson U, Sonestedt E, Visvanathan K, Jones MR, Relton C, Brennan P, Johansson M, Ulvik A.

Int J Cancer. 2018 Jun 15;142(12):2425-2434. doi: 10.1002/ijc.31215. Epub 2018 Jan 4.

8.

Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).

Fanidi A, Muller DC, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Thomsen CA, Pettinger M, Cai Q, Blot WJ, Wu J, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Han J, Stampfer MJ, Smith-Warner SA, Giovannucci E, Giles GG, Hodge AM, Severi G, Johansson M, Grankvist K, Langhammer A, Krokstad S, Næss M, Wang R, Gao YT, Butler LM, Koh WP, Shu XO, Xiang YB, Li H, Zheng W, Lan Q, Visvanathan K, Bolton JH, Ueland PM, Midttun Ø, Ulvik A, Caporaso NE, Purdue M, Ziegler RG, Freedman ND, Buring JE, Lee IM, Sesso HD, Gaziano JM, Manjer J, Ericson U, Relton C, Brennan P, Johansson M.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx119.

9.

Regarding the article of Manczuk et al. (2017; 230: 549-555) entitled "Ideal cardiovascular health is associated with self-rated health status. The Polish Norwegian Study (PONS)."

Gaye B, Pechmajou L, Fanidi A, Li C, Tafflet M.

Int J Cardiol. 2017 Jul 15;239:30. doi: 10.1016/j.ijcard.2017.03.159. No abstract available.

PMID:
28560976
10.

Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations.

Midttun Ø, Theofylaktopoulou D, McCann A, Fanidi A, Muller DC, Meyer K, Ulvik A, Zheng W, Shu XO, Xiang YB, Prentice R, Thomson CA, Pettinger M, Giles GG, Hodge A, Cai Q, Blot WJ, Wu J, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough ML, Weinstein SJ, Albanes D, Langhammer A, Hveem K, Næss M, Sesso HD, Gaziano JM, Buring JE, Lee IM, Severi G, Zhang X, Han J, Stampfer MJ, Smith-Warner SA, Zeleniuch-Jacquotte A, le Marchand L, Yuan JM, Butler LM, Koh WP, Wang R, Gao YT, Ericson U, Sonestedt E, Ziegler RG, Freedman ND, Visvanathan K, Jones MR, Relton C, Brennan P, Johansson M, Ueland PM.

Am J Clin Nutr. 2017 Jun;105(6):1314-1326. doi: 10.3945/ajcn.116.151241. Epub 2017 Apr 19.

11.

Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies.

Brenner DR, Fanidi A, Grankvist K, Muller DC, Brennan P, Manjer J, Byrnes G, Hodge A, Severi G, Giles GG, Johansson M, Johansson M.

Am J Epidemiol. 2017 Jan 15;185(2):86-95. doi: 10.1093/aje/kww159. Epub 2016 Dec 20.

PMID:
27998891
12.

Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort.

Fanidi A, Muller DC, Midttun Ø, Ueland PM, Vollset SE, Relton C, Vineis P, Weiderpass E, Skeie G, Brustad M, Palli D, Tumino R, Grioni S, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Boutron-Ruault MC, Kvaskoff M, Cadeau C, Huerta JM, Sánchez MJ, Agudo A, Lasheras C, Quirós JR, Chamosa S, Riboli E, Travis RC, Ward H, Murphy N, Khaw KT, Trichopoulou A, Lagiou P, Papatesta EM, Boeing H, Kuehn T, Katzke V, Steffen A, Johansson A, Brennan P, Johansson M.

Sci Rep. 2016 Nov 4;6:36017. doi: 10.1038/srep36017.

13.

Anthropometry and the Risk of Lung Cancer in EPIC.

Dewi NU, Boshuizen HC, Johansson M, Vineis P, Kampman E, Steffen A, Tjønneland A, Halkjær J, Overvad K, Severi G, Fagherazzi G, Boutron-Ruault MC, Kaaks R, Li K, Boeing H, Trichopoulou A, Bamia C, Klinaki E, Tumino R, Palli D, Mattiello A, Tagliabue G, Peeters PH, Vermeulen R, Weiderpass E, Torhild Gram I, Huerta JM, Agudo A, Sánchez MJ, Ardanaz E, Dorronsoro M, Quirós JR, Sonestedt E, Johansson M, Grankvist K, Key T, Khaw KT, Wareham N, Cross AJ, Norat T, Riboli E, Fanidi A, Muller D, Bueno-de-Mesquita HB.

Am J Epidemiol. 2016 Jul 15;184(2):129-39. doi: 10.1093/aje/kwv298. Epub 2016 Jul 1.

14.

Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design.

Han W, Ding Y, Xu Y, Pfister K, Zhu S, Warne B, Doyle M, Aikawa M, Amiri P, Appleton B, Stuart DD, Fanidi A, Shafer CM.

J Med Chem. 2016 Apr 14;59(7):3034-45. doi: 10.1021/acs.jmedchem.5b01657. Epub 2016 Mar 29.

PMID:
27002243
15.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and breast cancer risk in the Cancer de Màma (CAMA) study.

Fanidi A, Ferrari P, Biessy C, Ortega C, Angeles-Llerenas A, Torres-Mejia G, Romieu I.

Public Health Nutr. 2015 Dec;18(18):3337-48. doi: 10.1017/S1368980015000634. Epub 2015 Mar 25.

PMID:
25805146
16.

Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.

Johansson M, Fanidi A, Muller DC, Bassett JK, Midttun Ø, Vollset SE, Travis RC, Palli D, Mattiello A, Sieri S, Trichopoulou A, Lagiou P, Trichopoulos D, Ljungberg B, Hallmans G, Weiderpass E, Skeie G, González CA, Dorronsoro M, Peeters PH, Bueno-de-Mesquita HB, Ros MM, Boutron Ruault MC, Fagherazzi G, Clavel F, Sánchez MJ, Gurrea AB, Navarro C, Quiros JR, Overvad K, Tjønneland A, Aleksandrova K, Vineis P, Gunter MJ, Kaaks R, Giles G, Relton C, Riboli E, Boeing H, Ueland PM, Severi G, Brennan P.

J Natl Cancer Inst. 2014 Nov 5;106(12). pii: dju327. doi: 10.1093/jnci/dju327. Print 2014 Dec.

17.

Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.

Rubio CA, Weisburd B, Holderfield M, Arias C, Fang E, DeRisi JL, Fanidi A.

Genome Biol. 2014;15(10):476.

18.

Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.

Muller DC, Fanidi A, Midttun Ø, Steffen A, Dossus L, Boutron-Ruault MC, Severi G, Kühn T, Katzke V, de la Torre RA, González CA, Sánchez MJ, Dorronsoro M, Santiuste C, Barricarte A, Khaw KT, Wareham N, Travis RC, Trichopoulou A, Giotaki M, Trichopoulos D, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Tjønneland A, Olsen A, Bueno-de-Mesquita HB, Peeters PH, Ljungberg B, Wennberg M, Weiderpass E, Murphy N, Riboli E, Ueland PM, Boeing H, Brennan P, Johansson M.

Am J Epidemiol. 2014 Oct 15;180(8):810-20. doi: 10.1093/aje/kwu204. Epub 2014 Sep 8.

PMID:
25205830
19.

A prospective study of one-carbon metabolism biomarkers and cancer of the head and neck and esophagus.

Fanidi A, Relton C, Ueland PM, Midttun Ø, Vollset SE, Travis RC, Trichopoulou A, Lagiou P, Trichopoulos D, Bueno-de-Mesquita HB, Ros M, Boeing H, Tumino R, Panico S, Palli D, Sieri S, Vineis P, Sánchez MJ, Huerta JM, Barricarte Gurrea A, Luján-Barroso L, Quirós JR, Tjønneland A, Halkjær J, Boutron-Ruault MC, Clavel-Chapelon F, Cadeau C, Weiderpass E, Johansson M, Riboli E, Brennan P, Johansson M.

Int J Cancer. 2015 Feb 15;136(4):915-27. doi: 10.1002/ijc.29051. Epub 2014 Jul 7.

20.

Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk.

Chuang SC, Fanidi A, Ueland PM, Relton C, Midttun O, Vollset SE, Gunter MJ, Seckl MJ, Travis RC, Wareham N, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Bueno-de-Mesquita HB, Boeing H, Wientzek A, Kuehn T, Kaaks R, Tumino R, Agnoli C, Palli D, Naccarati A, Aicua EA, Sánchez MJ, Quirós JR, Chirlaque MD, Agudo A, Johansson M, Grankvist K, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Weiderpass E, Riboli E, Brennan PJ, Vineis P, Johansson M.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):461-8. doi: 10.1158/1055-9965.EPI-13-0770. Epub 2013 Dec 19.

21.

Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer.

Damiano JS, Rendahl KG, Karim C, Embry MG, Ghoddusi M, Holash J, Fanidi A, Abrams TJ, Abraham JA.

Mol Cancer Ther. 2013 Mar;12(3):295-305. doi: 10.1158/1535-7163.MCT-12-0886. Epub 2012 Dec 27.

22.

Suppression of c-Myc-induced apoptosis by the Epstein-Barr virus gene product BHRF1.

Fanidi A, Hancock DC, Littlewood TD.

J Virol. 1998 Oct;72(10):8392-5.

23.

Integrated control of cell proliferation and cell death by the c-myc oncogene.

Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M.

Philos Trans R Soc Lond B Biol Sci. 1994 Aug 30;345(1313):269-75. Review.

PMID:
7846125
24.

c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.

Harrington EA, Bennett MR, Fanidi A, Evan GI.

EMBO J. 1994 Jul 15;13(14):3286-95.

25.

Applications of apoptosis: making death pay.

Fanidi A, Evan G.

Trends Biotechnol. 1994 Jun;12(6):219-21. No abstract available.

PMID:
7765068
26.

Oncogenes and cell death.

Harrington EA, Fanidi A, Evan GI.

Curr Opin Genet Dev. 1994 Feb;4(1):120-9. Review.

PMID:
8193531
27.

Fluorimetric studies of calmodulin interactions with antiestrogens.

Fanidi A, Guichard Y, Fayard JM, Pageaux JF, Laugier C.

Cancer Detect Prev. 1994;18(6):471-8.

PMID:
7867020
28.

Cooperative interaction between c-myc and bcl-2 proto-oncogenes.

Fanidi A, Harrington EA, Evan GI.

Nature. 1992 Oct 8;359(6395):554-6.

PMID:
1406976
29.

In vivo inhibition of basal and estrogen-induced phospholipase A2 activities by the triphenylethylene antiestrogen, tamoxifen, in immature quail oviduct.

Fayard JM, Chanal S, Fanidi A, Pageaux JF, Lagarde M, Laugier C.

Eur J Pharmacol. 1992 May 27;216(1):127-30.

PMID:
1526252
30.
31.

Dissociated effects of tamoxifen on growth and on progesterone receptor induction in quail oviduct.

Laugier C, Fanidi A, Dufrene L, Fayard JM, Pageaux JF.

Gen Comp Endocrinol. 1991 Sep;83(3):439-46.

PMID:
1936925
32.

Differential regulation of calmodulin-dependent and -independent cyclic AMP phosphodiesterases from oviduct by fatty acids.

Laugier C, Zebda N, Fanidi A, Lagarde M, Pageaux F.

Biochem Biophys Res Commun. 1991 May 31;177(1):324-9.

PMID:
1645959
33.

Growth inhibition and the regulation of cyclic AMP by the triphenylethylene anti-estrogen tamoxifen in the quail oviduct.

Fanidi A, Pageaux JF, Courion C, Fayard JM, Laugier C.

Biol Cell. 1991;72(1-2):181-6.

PMID:
1661631
34.

Modulation of quail oviduct adenylate cyclase activity by estradiol and progesterone.

Courion-Guichardaz C, Fanidi A, Pageaux JF, Laugier C.

J Steroid Biochem. 1990 Mar;35(3-4):441-7.

PMID:
2325410
36.

Biochemical characterization and subunit structure of quail oviduct progesterone receptor.

Dufrene L, Pageaux JF, Fanidi A, Renoir JM, Laugier C, Baulieu EE.

J Steroid Biochem. 1989 May;32(5):703-13.

PMID:
2739411
37.

Effect of estrogen on adenosine 3'5',cyclic monophosphate in quail oviduct: possible involvement in estradiol-activated growth.

Laugier C, Courion C, Pageaux JF, Fanidi A, Dumas MY, Sandoz D, Nemoz G, Prigent AF, Pacheco H.

Endocrinology. 1988 Jan;122(1):158-64.

PMID:
2826110
38.

Cyclic nucleotide phosphodiesterase activity in the quail oviduct: hormonal regulation and involvement in estrogen-induced growth.

Dumas MY, Fanidi A, Pageaux JF, Courion C, Nemoz G, Prigent AF, Pacheco H, Laugier C.

Endocrinology. 1988 Jan;122(1):165-72.

PMID:
2446855

Supplemental Content

Loading ...
Support Center